Sanofi Q1 net profit rises 9.6% but sales slip


Sanofi's (SNY) Q1 net profit increased 9.6% to €1.08B as costs related to previous acquisitions fell.

However, revenue fell 2.6% to €7.84B and undershot forecasts of €7.99B, hurt by falling vaccine and animal health sales, and currency fluctuations.

Adjusted income dropped 3.2% to €1.55B and missed consensus of €1.57B.

Sales breakdown: Vaccines -9.9% to €628M; animal health -6.7% to €517M; pharmaceuticals -1.6% to €6.7B; diabetes +13% at constant currencies to €1.66B.

Shares are -2% in Paris. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs